Business Insider
My Markets Watchlist
Markets Stocks

Hyperfine Inc Registered Shs Stock , HYPR

0.72 -0.01 -0.96%
03:31:59 PM EDT 6/13/2025 BTT
News Analyst Data Analyst Opinions Insider Activity Dividend Calendar

On Friday 06/13/2025 the closing price of the Hyperfine Inc Registered Shs share was $0.73 on BTT. Compared to the opening price on Friday 06/13/2025 on BTT of $0.73, this is a gain of 0.11%. Hyperfine Inc Registered Shs's market capitalization is $45.60 M by 62.78 M shares outstanding.

Hyperfine Stock Snapshot

0.72
Bid
400.00
Bid Size
0.93
Ask
300.00
Ask Size
6/13/2025
Date
3:31 PM
Time
600.00
Volume
0.73
Prev. Close
0.73
Open
56.20 M
Market Cap in USD
62.78 M
Number of Shares
77.84 M
Total Number of Shares
0.72
Day Low
0.74
Day High
0.72
0.54
52 Week Low
1.90
52 Week High
0.72
0.00
Dividend in USD
0.00
Dividend Yield
91.78
Free Float in %
-0.56
EPS in USD
0.67
Book Value per Share in USD
-0.54
Cash Flow per Share in USD

Historical Prices for Hyperfine

Loading..
Date Open Close Daily High Daily Low
Price change over selected period: 0% 0

Hyperfine Analyst Data

Total Analysts: 5
Buy Ratings: 1 Neutral Ratings: 4 Sell Ratings: 0
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price *Price Target
Lowest: 0.68 Median: 1.26 Highest: 1.60
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

Hyperfine Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
Date Analyst Rating Price
05/14/25 Wells Fargo & Co
Maintained Hold $0.680000007152557
03/24/25 Lake Street
Maintained Buy $1.5
03/18/25 Wells Fargo & Co
Maintained Hold $1.28999996185303
03/22/24 Wells Fargo & Co
Maintained Hold $1.60000002384186
11/30/23 Jefferies & Company Inc.
Maintained Hold $1.25

Hyperfine Estimates* in USD

  2025 2026 2027 2028 2029
Revenue 14 18 20 25 -
Dividend - - - - -
Dividend Yield (in %) - - - - -
EPS -0.45 -0.40 -0.37 -0.34 -
P/E Ratio -1.59 -1.81 -1.95 -2.12 -4.41
EBIT -38 -31 -29 -27 -
EBITDA -36 -28 -26 - -
Net Profit -35 -31 -29 -27 -
Net Profit Adjusted -34 -27 -27 - -
Pre-Tax Profit -35 -31 -29 -27 -
Pre-Tax Profit Reported - - - - -
EPS (Non-GAAP) ex. SOE - - - - -
EPS (GAAP) -0.46 -0.36 -0.36 - -
Gross Income 7 9 11 15 -
Cash Flow from Investing - - - - -
Cash Flow from Operations - - - - -
Cash Flow from Financing - - - - -
Cash Flow per Share - - - - -
Free Cash Flow -38 -45 - - -
Free Cash Flow per Share - - - - -
Book Value per Share - - - - -
Net Debt - - - - -
Research & Development Exp. 18 15 14 15 -
Capital Expenditure - - - - -
Selling, General & Admin. Exp. 26 25 26 27 -
Shareholder’s Equity - - - - -
Total Assets - - - - -
  Previous Quarter
ending 03/31/25 		Current Quarter
ending 06/30/25 		Next Quarter
ending 09/30/25 		Current Year
ending 12/31/25 		Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts - 4 4 4 3
Average Estimate - -0.118 USD -0.107 USD -0.455 USD -0.399 USD
Year Ago - -0.141 USD -0.142 USD -0.562 USD -
Publish Date - 8/7/2025 11/6/2025 - -
Revenue Estimates
No. of Analysts - 4 4 4 3
Average Estimate - 3 USD 4 USD 14 USD 18 USD
Year Ago - 4 USD 4 USD 13 USD -
Publish Date - 8/7/2025 11/6/2025 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2024 2023 2022 2021 2020
Sales 12.89 11.03 6.81 1.50 0.00
Change of sales in % 16.84 61.90 355.48 - -
Gross profit on sales 5.89 4.76 0.91 -1.17 0.00
Gross profit on sales change in % 23.84 424.48 - - -
Operating income -43.22 -48.12 -72.79 -64.87 -0.01
Operating income change in % 10.17 33.90 -12.22 -1,297,260.00 -
Income before tax -40.72 -44.24 -73.16 -64.85 -0.01
Income before tax change in % 7.95 39.54 -12.82 -1,296,920.00 -
Income after tax -40.72 -44.24 -73.16 -64.85 -0.01
Income after tax change in % 7.95 39.54 -12.82 -1,296,920.00 -

Balance Sheet in Mio. USD

2024 2023 2022 2021 2020
Total liabilities 9.86 9.80 10.33 16.25 0.28
Long-term liabilities per share 0.02 0.01 0.02 0.01 0.00
Equity 49.04 84.40 123.72 186.23 0.02
Equity change in % -41.90 -31.78 -33.56 931,035.00 -
Balance sheet total 58.90 94.20 134.05 202.47 0.30
Balance sheet total change in % -37.47 -29.73 -33.79 66,412.82 -

Key Data in USD

2024 2023 2022 2021 2020
Sales per share 0.18 0.15 0.10 0.02 0.00
P/E ratio (year end quote, basic EPS) - - - - -
P/E ratio (year end quote, diluted EPS) - - - - -
Dividend yield in % 0.00 0.00 0.00 0.00 -
Equity ratio in % 83.26 89.60 92.29 91.98 6.57
Debt ratio in % 16.74 10.40 7.71 8.02 93.43

Hyperfine Insider Activity

Name Date shares traded shares held Price type (sell/buy) option
TEISSEYRE THOMAS 05/15/2025 2,776.00 82,213.00 0.58 Sell No
TEISSEYRE THOMAS 02/17/2025 3,237.00 84,990.00 1.20 Sell No
TEISSEYRE THOMAS 11/17/2024 2,800.00 88,227.00 0.85 Sell No
TEISSEYRE THOMAS 08/15/2024 2,746.00 91,027.00 1.05 Sell No
TEISSEYRE THOMAS 08/15/2023 2,785.00 102,411.00 2.26 Sell No
Siddiqui Khan 08/15/2023 1,729.00 76,981.00 2.26 Sell No
Siddiqui Khan 05/15/2023 1,735.00 78,710.00 1.25 Sell No
Siddiqui Khan 02/15/2023 4,635.00 80,445.00 1.39 Sell No
Gupta Alok 02/15/2023 5,613.00 110,456.00 1.39 Sell No
HC Sponsor LLC 12/15/2022 5,534,000.00 n/a n/a Sell No
Sainz Maria 12/13/2022 5,000.00 39,425.00 0.95 Buy No
Sainz Maria 12/08/2022 12,425.00 34,425.00 0.85 Buy No
Sainz Maria 12/08/2022 12,425.00 34,425.00 0.85 Buy No
Sainz Maria 12/07/2022 2,575.00 22,161.00 0.83 Buy No
Sainz Maria 12/07/2022 2,575.00 22,161.00 0.83 Buy No
ROTHBERG JONATHAN M 11/29/2022 229,215.00 885,707.00 0.82 Buy No
ROTHBERG JONATHAN M 11/28/2022 47,007.00 656,492.00 0.72 Buy No
Paykel Neela 11/15/2022 1,895.00 113,172.00 0.84 Sell No
Gupta Alok 11/15/2022 2,227.00 116,069.00 0.84 Sell No
Siddiqui Khan 11/15/2022 1,039.00 85,080.00 84.00 Sell No
ROTHBERG JONATHAN M 11/14/2022 31,139.00 609,485.00 0.92 Buy No
ROTHBERG JONATHAN M 11/13/2022 34,488.00 578,346.00 0.89 Buy No
ROTHBERG JONATHAN M 08/15/2022 64,213.00 543,858.00 1.48 Buy No
Siddiqui Khan 08/14/2022 1,035.00 86,119.00 1.45 Sell No
Paykel Neela 08/14/2022 1,891.00 115,067.00 1.45 Sell No

Hyperfine Dividend Calendar

Date Name Dividend *yield Currency
2024 Hyperfine Inc Registered Shs 0.00 0.00 USD
2023 Hyperfine Inc Registered Shs 0.00 0.00 USD
2022 Hyperfine Inc Registered Shs 0.00 0.00 USD
2021 Hyperfine Inc Registered Shs 0.00 0.00 USD
2020 Hyperfine Inc Registered Shs - - USD
*Yield of the Respective Date

Hyperfine Calendar

Event Estimate Info Date
Earnings Report -0.118 USD Q2 2025 Earnings Release 08/07/2025
Earnings Report -0.107 USD Q3 2025 Earnings Release 11/06/2025
Earnings Report -0.107 USD Q4 2025 Earnings Release 03/25/2026
Earnings Report -0.102 USD Q1 2026 Earnings Release 05/07/2026

Hyperfine Past Events

Event Actual EPS Info Date
Annual General Meeting -0.562 USD Annual General Meeting 05/19/2025
Earnings Report -0.124 USD Q1 2025 Earnings Release 05/13/2025
Earnings Report -0.142 USD Q4 2024 Earnings Release 03/17/2025
Earnings Report -0.142 USD Q3 2024 Earnings Release 11/12/2024
Earnings Report -0.141 USD Q2 2024 Earnings Release 08/08/2024
Annual General Meeting -0.620 USD Annual General Meeting 06/11/2024
Earnings Report -0.137 USD Q1 2024 Earnings Release 05/13/2024
Earnings Report -0.149 USD Q4 2023 Earnings Release 03/21/2024
Earnings Report -0.151 USD Q3 2023 Earnings Release 11/09/2023
Earnings Report -0.149 USD Q2 2023 Earnings Release 08/14/2023
Annual General Meeting -1.039 USD Annual General Meeting 06/08/2023
Earnings Report -0.172 USD Q1 2023 Earnings Release 05/11/2023
Earnings Report -0.185 USD Q4 2022 Earnings Release 03/21/2023
Earnings Report -0.187 USD Q3 2022 Earnings Release 11/10/2022
Earnings Report -0.329 USD Q2 2022 Earnings Release 08/10/2022
Annual General Meeting -0.922 USD Annual General Meeting 06/08/2022
Earnings Report -0.338 USD Q1 2022 Earnings Release 05/11/2022
Earnings Report -0.371 USD Q4 2021 Earnings Release 03/23/2022

Hyperfine Profile

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
OSZAR »